Associations of Fish Consumption With Risk of Cardiovascular Disease and Mortality Among Individuals With or Without Vascular Disease From 58 Countries
Open Access
- 1 May 2021
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 181 (5), 631-649
- https://doi.org/10.1001/jamainternmed.2021.0036
Abstract
Dietary guidelines recommend at least 2 servings of fish per week for the prevention of cardiovascular disease (CVD).1,2 Fish is a major source of the long-chain ω-3 fatty acids docosahexaenoic acid and eicosapentaenoic acid, which have been suggested to have beneficial effects on cardiovascular health.3-5 In interventional studies, fish and ω-3 consumption have been shown to improve some cardiovascular risk markers, including triglycerides and blood pressure, especially in people with triglycerides of 500 mg/dL or greater (to convert to millimoles per liter, multiply by 0.0113).6,7 Two recent meta-analyses of randomized trials in high-risk individuals showed that ω-3 supplementation (typically approximately 1 g/d) was not associated with risk of cardiovascular events, coronary heart deaths, coronary heart disease events, stroke, heart irregularities, or all-cause mortality.8,9 By contrast, another recent meta-analysis10 that included 3 new trials11-13 showed that ω-3 supplementation was associated with significant benefit against risk of CVD outcomes (summary relative risk of 0.92; 95% CI, 0.86-0.98),10 even after excluding a recent trial of patients with elevated triglyceride levels that used a much higher dose of fish oil (4 g daily).13 Observational cohorts of participants without diagnosed vascular disease have found modest protective associations of moderate fish consumption (approximately ≥2 servings/wk) with fatal coronary heart disease (ie, summary relative risks in multiple meta-analyses ranging from 2% to 15% lower risk) and, usually less strongly, with total CVD.14 To date, most cohort studies evaluating fish consumption and CVD events have been conducted in Europe, North America, Japan, and China, with little information from other world regions, where varying amounts and types of fish are consumed. Furthermore, whether the associations of fish consumption with CVD events vary between those with and those without vascular disease is unclear.Keywords
This publication has 51 references indexed in Scilit:
- Executive Summary: Heart Disease and Stroke Statistics—2013 UpdateCirculation, 2013
- Do Omega-3 Polyunsaturated Fatty Acids Prevent Cardiovascular Disease? A Review of the Randomized Clinical TrialsLipid Insights, 2013
- n–3 Fatty Acids and Cardiovascular Outcomes in Patients with DysglycemiaThe New England Journal of Medicine, 2012
- Fish Consumption, Dietary Long-Chain n-3 Fatty Acids, and Risk of Type 2 DiabetesDiabetes Care, 2012
- Omega-3 Fatty Acids and Cardiovascular Disease: Effects on Risk Factors, Molecular Pathways, and Clinical EventsJournal of the American College of Cardiology, 2011
- Fatty fish in the diet of patients with type 2 diabetes: comparison of the metabolic effects of foods rich in n–3 and n–6 fatty acidsThe American Journal of Clinical Nutrition, 2011
- Omega‐3 Dietary Supplements and the Risk of Cardiovascular Events: A Systematic ReviewClinical Cardiology, 2009
- Walnuts and fatty fish influence different serum lipid fractions in normal to mildly hyperlipidemic individuals: a randomized controlled studyThe American Journal of Clinical Nutrition, 2009
- Lack of benefit of dietary advice to men with angina: results of a controlled trialEuropean Journal of Clinical Nutrition, 2003
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986